|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||69.36 / 95.00|
The prices of generic drugs are declining as more of them are becoming available on the market along with pressure from major retail pharmacies.
It is just not going to get better anytime soon.
Teva's stock is crumbling as another analyst slams it with a downgrade.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AEL, CNMD, DATA, IAC, KBR, KHC, KOP, NPO, PBR.A, REG, SHAK, SQ, STOR, WMS, XPO Downgrades: ABC, AXTA, BIO, BIO.B, CNSL, DISH, GNE, HL, MCS, TGP, TNK, WEYS, WRLD Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
Teva said weak U.S. markets and the ongoing political turmoil in Venezuela weighed on the company's second quarter performance.
AmerisourceBergen Corporation (NYSE:ABC) today reported that in its fiscal year 2017 third quarter ended June 30, 2017, revenue increased 4.
The deal is worth $1.4 billion and PharMerica's board has already given it the green light.
McCaskill requested that four more drug companies and three drug distributors turn over documents.
McKesson faced some opposition at its shareholder meeting from an unconventional activist investor—a labor union.
ISS and Glass, Lewis echo the union's call for management to address the drug distributor's role in the opioid crisis.
AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Third Quarter Fiscal 2017 on Thursday, August 3, 2017 prior to the opening of trading on the New York Stock Exchange.
AmerisourceBergen (NYSE: ABC) today announced a new organizational structure designed to further align the organization to its customer needs in a more seamless and unified way, while supporting corporate strategy and...
Generic drugmakers are likely to limit themselves to acquisitions of small- and mid-sized companies in the immediate future because of over-leveraging and turmoil in the executive ranks..
The drug distributor is scheduled to report quarterly results after the market close on Thursday.
Here are Wednesday's top research calls, including new coverage of Advanced Micro Devices and Transocean, upgrades for Clovis Oncology and ConocoPhillips, and a downgrade for Disney.
AmerisourceBergen Corporation (NYSE:ABC) today reported that in its fiscal year 2017 second quarter ended March 31, 2017, revenue increased 4.
AmerisourceBergen Corporation (NYSE:ABC) announced today that it has signed a new five-year agreement to supply pharmaceuticals to Express Scripts Holding Company (Nasdaq: ESRX).
AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Second Quarter Fiscal 2017 on Thursday, May 4, 2017 prior to the opening of trading on the New York Stock Exchange.
The most recent short interest data has been released for the 02/28/2017 settlement date, which shows a 1,889,255 share increase in total short interest for AmerisourceBergen Corp. , to 16,609,081, an increase of 12.83% since 01/31/2017.
The Ways and Means panel had it easy compared to the Energy and Commerce Committee, which was still debating Democratic amendments Thursday morning-roughly 24 hours after beginning debate.
Akorn and AmerisourceBergen are both flashing big moves, but in which direction is unclear.
The pharmaceutical distributor is finally turning around.
Demographics will continue to favor health-care and pharmaceutical companies.
AmerisourceBergen Corporation (NYSE:ABC) today reported that in its fiscal year 2017 first quarter ended December 31, 2016, revenue increased 4 percent to $38.
Jim Cramer says it's not hard to find great American companies that have soared from Dow 10,000 to Dow 20,000.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.